DOI: 10.2337/dc07-0265 © 2007 by the American Diabetes Association
Retinopathy Predicts Cardiovascular Mortality in Type 2 Diabetic Men and WomenResponse to Juutilainen et al.
1 Diabetes Unit, "Sacro Cuore" Hospital of Negrar, Negrar, Verona, Italy Address correspondence to Giovanni Targher, MD, Diabetes Unit, Ospedale "Sacro Cuore don Calabria", Via Sempreboni, 5, 37024 Negrar (VR), Italy. E-mail: targher{at}sacrocuore.it
We read with interest the recent article by Juutilainen et al. (1) showing that proliferative retinopathy in both sexes and nonproliferative retinopathy in women independently predict all-cause and cardiovascular disease (CVD)-associated death. The authors have cautiously concluded that the sex difference observed in the association between nonproliferative retinopathy and cardiovascular death needs to be confirmed in larger studies. Indeed, I think the relatively low frequency of retinopathy (23%) and the relatively high cut-off chosen for diagnosing hypertension (blood pressure
Previously, we found that retinopathy is associated with an increased CVD incidence among 744 type 2 diabetic patients followed for 5 years (2). This association was largely explained by occurrence of traditional risk factors, especially hypertension (defined as blood pressure Recently, we have reevaluated the CVD outcomes among 2,103 type 2 diabetic participants of the Valpolicella Heart Diabetes Study during an extended follow-up of 6.5 years. A total of 384 participants (63% men, mean age 62 ± 4 years, with diabetes duration 16 ± 3 years) developed incident CVD events (myocardial infarction, ischemic stroke, coronary revascularization, or cardiovascular death), whereas 1,719 participants remained free of diagnosed CVD during follow-up. At baseline, a single ophthalmologist diagnosed retinopathy after pupillary dilation, according to a clinical disease severity scale (3).
Overall, 987 (46.9%) participants had retinopathy, of whom 798 had nonproliferative and 189 had proliferative retinopathy (confirmed by fluorescein angiography). After adjustment for age, BMI, smoking status, lipids, A1C, and diabetes duration and treatment, those with nonproliferative or proliferative retinopathy had a higher risk (P < 0.001) of incident CVD than those without retinopathy (hazard ratio 1.57 [95% CI 1.182.51] and 3.72 [2.117.58] for men; 1.63 [1.232.56] and 3.77 [2.157.83] for women, respectively). Further adjustment for hypertension (blood pressure These results extend our previous findings showing that retinopathy is associated with an increased CVD incidence in people with type 2 diabetes. However, this association appears to be principally explained by occurrence of hypertension and proteinuria. Moreover, our results do not support any significant sex difference in the adverse impact of retinopathy on incident CVD events. References
This article has been cited by other articles:
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||